332 related articles for article (PubMed ID: 29884437)
1. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
Shah R; Xia C; Krailo M; Amatruda JF; Arul SG; Billmire DF; Brady WE; Covens A; Gershenson DM; Hale JP; Hurteau J; Murray MJ; Nicholson JC; Olson TA; Pashankar F; Rodriguez-Galindo C; Shaikh F; Stark D; Frazier AL; Stoneham S
Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
[TBL] [Abstract][Full Text] [Related]
2. Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium.
Frazier AL; Stoneham S; Rodriguez-Galindo C; Dang H; Xia C; Olson TA; Murray MJ; Amatruda JF; Shaikh F; Pashankar F; Billmire D; Krailo M; Stark D; Brougham MFH; Nicholson JC; Hale JP
Eur J Cancer; 2018 Jul; 98():30-37. PubMed ID: 29859339
[TBL] [Abstract][Full Text] [Related]
3. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.
Newton C; Murali K; Ahmad A; Hockings H; Graham R; Liberale V; Sarker SJ; Ledermann J; Berney DM; Shamash J; Banerjee S; Stoneham S; Lockley M
Eur J Cancer; 2019 May; 113():19-27. PubMed ID: 30954883
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
[TBL] [Abstract][Full Text] [Related]
5. Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII).
Depani S; Stoneham S; Krailo M; Xia C; Nicholson J
Eur J Cancer; 2019 Sep; 118():49-57. PubMed ID: 31306943
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
[TBL] [Abstract][Full Text] [Related]
7. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of ovarian germ cell tumors.
Williams SD
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1261-9. PubMed ID: 1663943
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162
[TBL] [Abstract][Full Text] [Related]
10. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Terenziani M; Bisogno G; Boldrini R; Cecchetto G; Conte M; Boschetti L; De Pasquale MD; Biasoni D; Inserra A; Siracusa F; Basso ME; De Leonardis F; Di Pinto D; Barretta F; Spreafico F; D'Angelo P
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449306
[TBL] [Abstract][Full Text] [Related]
11. [Ovarian malignant tumours. Efficacy of germ cell and sex cord tumour treatment protocol in Poland].
Popadiuk S; Korzon M; Chybicka A; Szmyd K; Dzierzega M; Trelińska J; Kowalczyk JR; Wiśniewska-Slusarz H; Woźniak W; Bilska K; Wachowiak J; Konatkowska B; Wysocki M; Krawczuk-Rybak M; Czauderna P; Szumera M; Sznurkowska K; Renke J
Med Wieku Rozwoj; 2006; 10(3 Pt 1):803-10. PubMed ID: 17317911
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.
Williams SD; Kauderer J; Burnett AF; Lentz SS; Aghajanian C; Armstrong DK
Gynecol Oncol; 2004 Dec; 95(3):496-9. PubMed ID: 15581952
[TBL] [Abstract][Full Text] [Related]
13. Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85/90/95) with late effects study.
Duhil de Bénazé G; Pacquement H; Faure-Conter C; Patte C; Orbach D; Corradini N; Berger C; Sudour-Bonnange H; Vérité C; Martelli H; Fresneau B
Eur J Cancer; 2018 Mar; 91():30-37. PubMed ID: 29331749
[TBL] [Abstract][Full Text] [Related]
14. Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau.
Germá JR; Izquierdo MA; Seguí MA; Climent MA; Ojeda B; Alonso C
Gynecol Oncol; 1992 May; 45(2):153-9. PubMed ID: 1375576
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of germ-cell ovarian tumours: first-line treatment with etoposide, bleomycin and cisplatin or carboplatin.
Smales E; Peckham MJ
Eur J Cancer Clin Oncol; 1987 May; 23(5):469-74. PubMed ID: 2443358
[TBL] [Abstract][Full Text] [Related]
16. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
[TBL] [Abstract][Full Text] [Related]
17. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
[TBL] [Abstract][Full Text] [Related]
18. Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India.
Vasanth A; Patel SM; Arora R; Parekh CD; Dave P; Patel BM; Vemanamandhi P
J Gynecol Oncol; 2024 Mar; 35(2):e19. PubMed ID: 37921603
[TBL] [Abstract][Full Text] [Related]
19. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer.
van der Burg ME; Onstenk W; Boere IA; Look M; Ottevanger PB; de Gooyer D; Kerkhofs LG; Valster FA; Ruit JB; van Reisen AG; Goey SH; van der Torren AM; ten Bokkel Huinink D; Kok TC; Verweij J; van Doorn HC
Eur J Cancer; 2014 Oct; 50(15):2592-601. PubMed ID: 25096168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
